| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/08/2009 | US20090010937 Membrane Attack Complexes Associated with Circulating Immune Complexes |
| 01/08/2009 | US20090010930 Antibodies to vla-1 |
| 01/08/2009 | US20090010926 Extended Treatment of Multiple Sclerosis |
| 01/08/2009 | US20090010911 Methods and compositions for affecting cyclophilin a regulation of kinases in modulating cellular activities |
| 01/08/2009 | US20090010904 Immunostimulating Agent and Method for Production Thereof |
| 01/08/2009 | US20090010885 Methods for Detecting and Treating Autoimmune Disorders |
| 01/08/2009 | DE102005054700B4 Neue duale Peptidase-Inhibitoren als Prodrugs zur Therapie von entzündlichen und anderen Erkrankungen New dual peptidase inhibitors as prodrugs for the treatment of inflammatory and other diseases |
| 01/08/2009 | CA2694354A1 Lactic acid bacteria-derived double-stranded rna |
| 01/08/2009 | CA2692509A1 Compounds and methods for the treatment of renal disease |
| 01/08/2009 | CA2691840A1 The use of monomycolyl glycerol (mmg) as an adjuvant |
| 01/08/2009 | CA2689116A1 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof |
| 01/07/2009 | EP2012123A1 Marker for predicting graft-versus-host disease and utilization of the same |
| 01/07/2009 | EP2011877A2 Conjugates for the modulation of immune responses |
| 01/07/2009 | EP2011870A1 Mutant polypeptide having effector function |
| 01/07/2009 | EP2011802A2 Anti-CD40 monoclonal antibody |
| 01/07/2009 | EP2011800A2 Inhibitors of caspase |
| 01/07/2009 | EP2011514A1 A preventive or therapeutic agent for sensitized T cell-mediated diseases comprising IL-6 antagonist as an active ingredient |
| 01/07/2009 | EP2011499A2 Pyrrolo[2,3d]Pyrimidine compositions and their use |
| 01/07/2009 | EP2010562A1 Novel polypeptides inducing dendritic cell migration, as well as medicines and pharmaceutical compositions containing same |
| 01/07/2009 | EP2010537A1 Imidazoquinoxaline compounds as immunomodulators |
| 01/07/2009 | EP2010524A2 S1p receptor modulating compounds |
| 01/07/2009 | EP2010197A2 A pharmaceutical composition useful as an immunomodulating agent and a process for the preparation thereof |
| 01/07/2009 | EP1928821B1 Carboxamide derivatives as muscarinic receptor antagonists |
| 01/07/2009 | EP1743651B1 Vaccine compositions which are obtained from streptomyces |
| 01/07/2009 | EP1580556B1 Functional domain and associated molecule of dock2 essentially required in lymphocyte migration |
| 01/07/2009 | EP1496942B1 Microparticles comprising carbohydrate beads covalently linked with allergen derived from plant pollen |
| 01/07/2009 | EP1431285B1 Reverse hydroxamic acid derivatives |
| 01/07/2009 | EP1409684B1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/07/2009 | EP1406641B1 Krill extracts for prevention and/or treatment of cardiovascular diseases |
| 01/07/2009 | EP1392662B1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments |
| 01/07/2009 | EP1357909B1 Il-8 receptor antagonists |
| 01/07/2009 | EP1320381B1 New immunogenic complex |
| 01/07/2009 | EP1257290B1 Method for antigen-specific stimulation of t-lymphocytes with synthetic peptide libraries |
| 01/07/2009 | EP1223973B1 Method of expressing antigens on the surface of antigen presenting cells by photochemical internalization |
| 01/07/2009 | EP1204665B1 Chemokine receptor antagonists and methods of use therefor |
| 01/07/2009 | EP1204425B1 Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein |
| 01/07/2009 | EP1198581B1 Method for reducing the antigenicity of adeno-associated virus structural protein |
| 01/07/2009 | EP0980389B1 Antigen |
| 01/07/2009 | EP0787008B1 Thymosin alpha1 in combination with a natural cytokine mixture for the treatment of a cellular immune deficiency |
| 01/07/2009 | CN101341246A The use of sirnas in organ storage/reperfusion solutions |
| 01/07/2009 | CN101341146A 3- (4- { [4-(4-{ [3-(3, 3-dimethyl-1-piperidinyl) propyl[oxy] phenyl) -1-piperidinyl carbonyl }-1-naphthalenyl) propanoic or propenoic acid as H1 and H3 receptor antagonists for the treatment of infla |
| 01/07/2009 | CN101341137A Pyrazine derivatives as epithelial sodium channel blocker |
| 01/07/2009 | CN101340934A Immuno-RNA-constructs |
| 01/07/2009 | CN101340927A Application of TGF-beta1 inhibitory polypeptide on immune response modifier preparation |
| 01/07/2009 | CN101340926A Method of treating myasthenia gravis |
| 01/07/2009 | CN101340922A Caltrop freeze-dry extract used for antiallergic treatment |
| 01/07/2009 | CN101340892A Use of a liquid allergy vaccine formulation for oromucosal administration |
| 01/07/2009 | CN101337871A Indandione compound |
| 01/07/2009 | CN101336896A New use of sodium houttutfonate injection in aspect of enhancing poultry immunity |
| 01/07/2009 | CN101336653A Biscuit formulation capable of enhancing immunity and preparation method thereof |
| 01/07/2009 | CN100448994C Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, proteins encoded, and uses thereof |
| 01/07/2009 | CN100448985C Educated NKT cells and their uses in the treatment of immune-related disorder |
| 01/07/2009 | CN100448891C Peptides and related molecules that bind to TALL-1 |
| 01/07/2009 | CN100448875C Substituted 1-piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 01/07/2009 | CN100448874C N-aroyl cyclic amines |
| 01/07/2009 | CN100448475C Dry concentrate of yellow wine and preparation method thereof |
| 01/07/2009 | CN100448470C Medicinal composition for immunological disease and its preparing method |
| 01/07/2009 | CN100448451C Nutritional compositions with contain slightly negatively charged, non-digestible polysaccharides and use thereof for reducing transport through tight junctions |
| 01/06/2009 | US7473779 e.g. 2-amino-N-(4-{[amino(2-thienyl)methylidene]amino}phenethyl)-5-methoxybenzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent |
| 01/06/2009 | US7473686 Thrombopoietin mimetics |
| 01/06/2009 | US7473536 To increase the titer of avipoxviruses produced from cells after infection of cells with the avipoxvirus, wherein the host range gene is expressed in cells |
| 01/06/2009 | US7473428 Vaccination of pigs against disease by administering a first recombinant porcine adenovirus vector stably expressing a heterologous nucleotide sequence encoding the antigenic determinant of the disease, preferably Hog Cholera Virus or Pseudorabies virus |
| 01/06/2009 | US7473425 Remedies for ischemic disease |
| 01/06/2009 | US7473420 Processing adipose tissue to deliver a concentrated amount of stem cells in a closed system so that the stem cells are not exposed to external environment by use of a pre-assembled, linked set of closed, sterile containers and tubing allowing for transfer of tissue and fluid elements within a closed path |
| 01/06/2009 | US7473247 Intradermal delivery of vaccines and gene therapeutic agents via microcannula |
| 01/06/2009 | CA2404335C Vitamin d compounds used to stabilize kidney transplants |
| 01/06/2009 | CA2369504C Pyrazole compositions useful as inhibitors of erk |
| 01/06/2009 | CA2348084C Crystallisation using supercritical or subcritical fluids |
| 01/06/2009 | CA2268138C Mycosis vaccines |
| 01/06/2009 | CA2216546C 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2-one derivatives having pde iv and cytokine inhibiting activity |
| 01/06/2009 | CA2181590C Peptomers with enhanced immunogenicity |
| 01/06/2009 | CA2120319C Pharmaceutical for the treatment of skin disorders |
| 01/02/2009 | DE60224401T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure |
| 01/01/2009 | US20090007280 Ange gene in atopy |
| 01/01/2009 | US20090005580 Compounds, compositions and methods |
| 01/01/2009 | US20090005426 Pharmaceutically active sulfonyl hydrazide derivatives |
| 01/01/2009 | US20090005421 Novel Pyridine Derivatives |
| 01/01/2009 | US20090005410 N-(4-Chloro-2-[1,2,3]triazolo[4,5-b]pyridin-1-yl-phenyl)-4-(1-hydroxy-1-methyl-ethyl)-benzene-sulfonamide sodium salt, used as chemokine receptors antagonists, useful for treating inflammation |
| 01/01/2009 | US20090005377 Pyrazolopyridine Derivates |
| 01/01/2009 | US20090005376 1-Alkoxy 1H-Imidazo Ring Systems and Methods |
| 01/01/2009 | US20090005351 Hormone replacement therapy |
| 01/01/2009 | US20090005348 Compounds Having Cytokine Modulating Properties |
| 01/01/2009 | US20090005340 Bioactive Agents Produced By Submerged Cultivation of a Basidiomycete Cell |
| 01/01/2009 | US20090005338 Carbonyl-substituted titanocenes |
| 01/01/2009 | US20090005334 Nucleic acid derivatives |
| 01/01/2009 | US20090005318 Controlled release composition and method of producing the same |
| 01/01/2009 | US20090005292 Novel Peptides that Bind to the Erythropoietin Receptor |
| 01/01/2009 | US20090004733 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides, and uses thereof |
| 01/01/2009 | US20090004722 bovine parainfluenza virus (bPIV) cDNA or RNA which may be used to express heterologous gene products; tumor antigens; cancer |
| 01/01/2009 | US20090004295 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 01/01/2009 | US20090004238 Implantation of encapsulated biological materials for treating diseases |
| 01/01/2009 | US20090004237 B7-Like Molecules and Uses Thereof |
| 01/01/2009 | US20090004227 Peroral Vaccine Carrier System |
| 01/01/2009 | US20090004223 A vaccine to prevent diarrhea by administering an immunogenic capsulated polysaccharide based on repeating units of an O-methyl phosphoramidated heptose disaccharide without concomitantly inducing Barre-Guillain Syndrome; bioconjugating with a carrier to effect enhanced T-cell dependent immunity |
| 01/01/2009 | US20090004218 Antigen-Carbohydrate Conjugates |
| 01/01/2009 | US20090004203 Methods of treating measles infectious disease in mammals |
| 01/01/2009 | US20090004199 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 01/01/2009 | US20090004194 Tlr agonist (flagellin)/cd40 agonist/antigen protein and dna conjugates and use thereof for inducing synergistic enhancement in immunity |
| 01/01/2009 | US20090004190 Rage Fusion Proteins And Methods Of Use |
| 01/01/2009 | US20090004178 Pharmaceutical compound for blocking the crt or erp57 translocation |